Skip to main content

Closed

CRBP: Corbus Pharmaceuticals Holdings, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

14thpctl

Volume

0.71×avg

Market Cap

166.19MUSD

P/E Ratio

-1.4TTM

Div Yield

-ann

Corbus Pharmaceuticals Holdings, Inc.

CRBPNASDAQ·USD·Closed

Corbus Pharmaceuticals Holdings, Inc.

CRBPNASDAQ·USD·Closed

$8.97

−0.88%

$8.97

−$0.08 (0.88%)

52W Range

14thpctl

Volume

0.71×avg

Mkt Cap

166.19MUSD

P/E

-1.4TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings